Home
Search
BIO International Convention   |   June 16-19, 2025

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Elizabeth Jeffords
PRESIDENT & CEO, IOLYX THERAPEUTICS
Planning for the Future: Building Inclusive Corporate Boards
Paul Jeffrey, PharmD
FORMER SENIOR DIRECTOR OF PHARMACY, MASSHEALTH
Case Study: Launching Successful Gene Therapies in the Value-Based Era
Quincy, Massachusetts, United States
Debra Jennings
HEAD OF PATIENT ACCESS AND SUPPORT, ONCOLOGY BUSINESS UNIT AT TAKEDA ONCOLOGY, TAKEDA PHARMACEUTICALS
Creating Commercial Advantage Through Diversity, Equity, and Inclusion
Cambridge, Massachusetts, United States
Amanda Jezek
SENIOR VICE PRESIDENT PUBLIC POLICY AND GOVERNMENT RELATIONS, INFECTIOUS DISEASES SOCIETY OF AMERICA (IDSA)
Tackling the Global Challenge of Antimicrobial Resistance: What Will It Take?
Ramsey Johnson
FOUNDER AND PRESIDENT, OUTBIO
Investing in the Value of DEI for Your Company and Community
Zoe Johnson, ACA
CHIEF SCIENTIFIC OFFICER, AFFIVANT SCIENCES GMBH
Affivant
Basel, Switzerland
Brian Johnston, PhD
CEO, SOMAGENICS, INC.
SomaGenics, Inc.
Santa Cruz, California, United States
Carrie Jones
PARTNER, HEALTH ADVANCES
Tailored Regulatory and Access Strategies to Drive Cell and Gene Therapy Innovation and Value for Clinical Developers
Brain Jones
SENIOR VICE PRESIDENT AND GENERAL MANAGER, IN REACH NETWORK
Dismantling Disparities in Healthcare through Partnerships and Policy
Troels Jordansen
CEO, GLYCOSTEM THERAPEUTICS
Glycostem Therapeutics B.V.
Oss, Netherlands